BioPharmSignal logoBioPharmSignal

Biotech News

RxSight, Inc. Reports Third Quarter 2026 Results

RxSight (RXST)RxSightEarnings

ALISO VIEJO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended September 30, 2026. Third Quarter 2026 Financial Highlights Total revenue of $24.6 million primarily driven by 23,128 Light Adjustable Lens™ (LAL™) units Cash,

Related news

RXSTRxSight2026-10-20 20:05 EST

RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3

TMCITreace Medical Concepts2026-11-06 12:05 EST

Treace Medical Concepts Reports Third Quarter 2026 Financial Results

CVRXCVRx2026-11-05 21:05 EST

CVRx Reports Third Quarter 2026 Financial and Operating Results

ICUIICU Medical2026-11-05 21:05 EST

ICU Medical Announces Third Quarter 2026 Results and Reaffirms Fiscal Year 2026 Guidance, Expecting Results at the High End of Range

AORTArtivion2026-11-05 21:05 EST

Artivion Reports Third Quarter 2026 Financial Results

PLSEPulse Biosciences2026-11-05 21:05 EST

Pulse Biosciences Reports Business Updates and Third Quarter 2026 Financial Results

APYXApyx Medical2026-11-05 12:00 EST

Apyx Medical Corporation Reports Third Quarter 2026 Financial Results

SGHTSight Sciences2026-11-04 21:05 EST

Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance

ADPTAdaptive Biotechnologies2026-11-04 21:05 EST

Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results

PRCTPROCEPT BioRobotics2026-11-04 21:05 EST

PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance

View all latest news

RxSight

Adjustable Cataract Lenses RxSight is an ophthalmic medical-device company focused on customized vision after cataract surgery. Light Adjustable Lens System The system combines an implantable Light Adjustable Lens with a Light Delivery Device. After surgery, physicians use ultraviolet light treatments to modify the lens and refine the...

Recent company news

RXSTRxSight2026-11-03 21:05 EST

RxSight, Inc. Reports Third Quarter 2026 Results

RXSTRxSight2026-10-24 00:00 EST

RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

RXSTRxSight2026-10-20 20:05 EST

RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3

RXSTRxSight2026-10-19 13:00 EST

RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation

RXSTRxSight2026-08-26 20:15 EST

RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference

Stock data

Close
4.54 USD
Market cap
204.5M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States